PREFERENTIAL GENERATION OF IPSC CARRYING ANTIGEN SPECIFIC TCRS FROM TUMOR INFILTRATING LYMPHOCYTES

Disclosed are methods for reprogramming cancer-reactive T cells into iPSC cells as well as methods utilizing such cells for the identification of cancer-antigen specific TCRs and the treatment of cancer.

Saved in:
Bibliographic Details
Main Authors ISLAM, SM Rafiqul, RESTIFO, Nicholas P, VIZCARDO, Raul E, MAEDA, Takuya, TAMAOKI, Naritaka
Format Patent
LanguageEnglish
French
German
Published 28.06.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are methods for reprogramming cancer-reactive T cells into iPSC cells as well as methods utilizing such cells for the identification of cancer-antigen specific TCRs and the treatment of cancer.
Bibliography:Application Number: EP20210769306